ANNX vs RARE · $268.1M cap vs rev $350.0M
Annexon Inc (ANNX) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Annexon Inc (ANNX) is a biotechnology company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
ANNX does not have a complete income-statement cache yet.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
ANNX currently screens at market cap $268.1M. RARE currently screens at market cap $2.79B.
Not investment advice. Open the ANNX and RARE stock pages for the full models.
Not investment advice.